VivoSeq
Other

Ovarian Function

0

Pipeline Programs

3

Active Trials

0

Companies Involved

Ovarian Function is an early-stage landscape with 0 programs across 0 companies.

Pipeline Metrics

Competitive Density

14/100

Pipeline Velocity

0/100

Mech. Concentration

N/A

Completion Rate

89/100

Attrition Rate

8/100

Programs by Phase

No pipeline programs currently tracked for this disease.

Trial Status

13

clinical trials

Completed8 · 62%
Recruiting2 · 15%
Withdrawn1 · 8%
Unknown status1 · 8%
Not yet recruiting1 · 8%

Trial Activity

13 trials

E4/DRSP Ovarian Function Inhibition Study
Completed·EEstetra·Phase 2·NCT03091595·82 enrolled
Ovarian Function With ENG Implant and UPA Use
Completed·UUniversity of Utah·Phase 1·NCT04291001·40 enrolled

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)